Edition:
United States

Aratana Therapeutics Inc (PETX.OQ)

PETX.OQ on NASDAQ Stock Exchange Global Market

5.80USD
18 Dec 2018
Change (% chg)

-- (--)
Prev Close
$5.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
82,976
52-wk High
$7.16
52-wk Low
$3.68

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 21.56 0.186
Jun '18 4.91 -0.138
Mar '18 4.04 -0.191
FY 2017 Dec '17 10.46 -0.367
Sep '17 6.16 -0.210
Jun '17 5.16 -0.258
Mar '17 3.80 -0.344
FY 2016 Dec '16 0.29 -0.638
Sep '16 0.04 -0.381
Jun '16 38.05 0.606
Mar '16 0.17 -0.520
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 9.05 20.20 5.25 15.81
Quarter Ending Mar-19 5 9.72 11.22 8.00 16.39
Year Ending Dec-18 3 36.33 36.98 35.10 37.42
Year Ending Dec-19 5 47.08 53.20 44.40 71.36
Earnings (per share)
Quarter Ending Dec-18 4 -0.09 -0.01 -0.14 -0.01
Quarter Ending Mar-19 3 -0.13 -0.07 -0.19 -0.08
Year Ending Dec-18 5 -0.40 -0.25 -0.61 -0.45
Year Ending Dec-19 5 -0.25 -0.10 -0.42 0.01
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.40
P/E High - Last 5 Yrs. -- 40.56 46.21
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta 3.45 0.91 0.91
Price to Sales (TTM) 29.50 4.00 6.22
Price to Book (MRQ) 2.70 5.02 5.20
Price to Tangible Book (MRQ) 5.65 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions 74.77 0.95 1.77

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -86.44 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago -75.89 4.80 6.50
Sales - 5 Yr. Growth Rate -- 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -142.60 17.47 23.27
EPS (TTM) vs TTM 1 Yr. Ago 13.25 -- --
EPS - 5 Yr. Growth Rate -- 9.89 10.50
Capital Spending - 5 Yr. Growth Rate 21.67 15.23 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.94 2.20 2.28
Current Ratio (MRQ) 4.24 3.02 3.10
LT Debt to Equity (MRQ) 29.28 8.88 11.49
Total Debt to Equity (MRQ) 38.07 12.68 16.03
Interest Coverage (TTM) -6.29 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 4.06 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -545.82 -- --
EBITD - 5 Yr. Avg -341.34 18.41 13.15
Operating Margin (TTM) -613.29 14.43 6.07
Operating Margin - 5 Yr. Avg. -482.27 14.55 8.46
Pre-Tax Margin (TTM) -642.93 14.96 7.01
Pre-Tax Margin - 5 Yr. Avg. -475.79 14.97 8.70
Net Profit Margin (TTM) -642.93 11.16 3.11
Net Profit Margin - 5 Yr. Avg. -436.25 11.23 4.90
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.66 23.84

Efficiency

  Company industry sector
Revenue/Employee (TTM) 110,536 997,079,883 873,071,763
Net Income/Employee (TTM) -710,667 118,240,509 103,486,133
Receivable Turnover (TTM) 3.78 5.82 5.80
Inventory Turnover (TTM) 1.87 2.68 3.56
Asset Turnover (TTM) 0.06 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -37.13 11.98 11.45
Return on Assets - 5 Yr. Avg. -30.68 13.28 12.50
Return on Investment (TTM) -43.08 15.55 14.96
Return on Investment - 5 Yr. Avg. -33.83 17.28 16.23
Return on Equity (TTM) -56.94 16.92 16.53
Return on Equity - 5 Yr. Avg. -45.95 18.21 17.37
  1 Year 3 Year 5 Year
Sales % 5,585.99 579.27 --
EPS (TTM) % 61.09 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aratana Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.26 5.50 77 20
13 Week -12.26 -16.53 25 34
26 Week 18.18 9.20 78 28
52 Week -34.06 -44.11 14 12
YTD -11.28 -22.09 30 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 68.39%
# of Holders: 140
Total Shares Held: 33,256,032
3 Mo. Net Change: 1,821,106
# New Positions: 14
# Closed Positions: 18
# Increased Positions: 53
# Reduced Positions: 58
# Net Buyers: -5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.